Abstract:Cardiovascular disease stands as the leading cause of death globally, claiming approximately 19 million lives in 2020. On the contrary, the development of cardiovascular drugs is experiencing a decline, largely due to the bottleneck in understanding the pathophysiology of various heart diseases and assessing the effects of drugs on healthy human hearts. The development of induced pluripotent stem cell (iPSC) technology and the availability of cardiac cell types in vitro, has resulted in a surge in efforts to fabricate human cardiac models for disease modelling and drug discovery applications. Although numerous attempts evidence successful fabrication of 3 dimensional (3D) engineered heart tissues, the innate immune cell population of the myocardium ;particularly cardiac macrophages, was until recently, overlooked. With increasing appreciation of the interactions between cardiomyocytes and macrophages in the myocardium, in this work, isogenic populations of cardiac resident-like macrophages and cardiomyocytes were generated using iPSCs, to understand the interactions between the two cell types in both 2D and 3D settings, and subjected to electric stimulation. After characterizing iPSC-derived macrophages (iMacs) and iPSC-derived cardiomyocytes (iCMs) in depth, the conditioning of iMacs to align to a cardiac resident macrophage-like phenotype in the presence of iCMs in 2D culture was explored. In coculture with iCMs, iMacs upregulated known genes expressed by cardiac resident macrophages. Additionally, in co-culture with iMacs, iCMs displayed an elongated morphology, improved calcium function and an increase in known maturation genes such as the ratio between MYH7 and MYH6 as well as SERCA2. In a 2D setting, iMacs showed the ability to electrically couple with iCMs and facilitate synchronous beating in iCM cultures. The 2D characterisation was translated into an engineered cardiac tissue model, wherein, improvement in tissue characteristics in the presence of iMacs was demonstrated in terms of increased cell alignment, enhanced cardiomyocyte elongation, physiologically relevant beat rates and improved tissue compaction. Taken together, these findings may open new avenues to use iMacs in engineered cardiac tissue models, not only as an innate immune cell source, but also as a support cell type to improve cardiomyocyte function and maturation.

Heart‐on‐a‐Chip Model of Epicardial‐Myocardial Interaction in Ischemia Reperfusion Injuryz

Heart‐on‐a‐Chip Model of Epicardial–Myocardial Interaction in Ischemia Reperfusion Injury (Adv. Healthcare Mater. 21/2024)

Epicardioid Single-Cell Genomics Uncovers Principles of Human Epicardium Biology in Heart Development and Disease

Design and fabrication of an integrated heart-on-a-chip platform for construction of cardiac tissue from human iPSC-derived cardiomyocytes and in situ evaluation of physiological function

Micro‐Engineered Heart Tissues on‐Chip with Heterotypic Cell Composition Display Self‐Organization and Improved Cardiac Function

Engineering Cardiac Tissue for Advanced Heart‐on‐a‐chip Platforms

Heart-on-a-chip systems with tissue-specific functionalities for physiological, pathological, and pharmacological studies

Heart-on-a-Chip Model with Integrated Extra- and Intracellular Bioelectronics for Monitoring Cardiac Electrophysiology under Acute Hypoxia

Epicardial cell participation in cardiac repair requires epithelial-to-mesenchymal transition

Establishment of a heart-on-a-chip microdevice based on human iPS cells for the evaluation of human heart tissue function

A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling

A heart-on-a-chip platform for online monitoring of contractile behavior via digital image processing and piezoelectric sensing technique

A Biomimetic Cardiac Fibrosis-on-a-Chip As a Visible Disease Model for Evaluating Mesenchymal Stem Cell-Derived Exosome Therapy.

Engineered Cardiac Microtissue Biomanufacturing Using Human Induced Pluripotent Stem Cell-Derived Epicardial Cells

Single-cell transcriptomics defines heterogeneity of epicardial cells and fibroblasts within the infarcted murine heart

Single-cell transcriptomics defines heterogeneity of epicardial cells and fibroblasts within the infarcted heart

Synergistic generation of cardiac resident-like macrophages and cardiomyocyte maturation in tissue engineered platforms

Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions

Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research

Experimentally-guided in silico design of engineered heart tissues to improve cardiac electrical function after myocardial infarction

In vivo grafting of large engineered heart tissue patches for cardiac repair